The Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) Protocol

Clinical trial NCT00246064 · COMPLETED

Trial details

NCT number: NCT00246064
Sponsor: Centocor Ortho Biotech Services, L.L.C.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Arthritis, Rheumatoid

Start date: 2001-12-01
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.